Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
36 hedge funds and large institutions have $64.6M invested in Biolase, Inc. in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 5 closing their positions.
900% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 1
53% more capital invested
Capital invested by funds: $42.2M → $64.6M (+$22.4M)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 35 → 36 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$7.1M |
| 2 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$5.16M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$2M |
| 4 |
D.E. Shaw & Co
New York
|
+$156K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$156K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$487K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$206K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$34K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$31.3K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$31.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Citigroup
New York
| – | -$3K | – | – |
|
BIOL Hedge Fund Activity: Q4 2014 in Review
36 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q4 2014, worth a combined $64.6M — up 53% from $42.2M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BIOL positions and 5 closed out — a net gain of 1 holder — while 10 added to existing stakes and 1 trimmed.
The largest buyer was Camber Capital Management, adding an estimated $7.1M. The largest seller was Wellington Management Group, exiting entirely with an estimated $487K sold.
- 36 institutional investors held Biolase, Inc. (BIOL) as of Q4 2014, up from 35 in Q3 2014.
- Funds reported $64.6M of Biolase, Inc. stock for Q4 2014, up 53% quarter-over-quarter.
- 6 funds opened new Biolase, Inc. positions in Q4 2014 and 5 closed out, a net change of +1 holder.
- The largest Biolase, Inc. buyer in Q4 2014 was Camber Capital Management, an estimated $7.1M added.
- The largest Biolase, Inc. seller in Q4 2014 was Wellington Management Group, an estimated $487K sold.
Based on aggregated 13F filings for Q4 2014.